DrugPatentWatch Database Preview
Profile for Ecuador Patent: SP088118
US Patent Family Members and Approved Drugs for Ecuador Patent: SP088118
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Feb 23, 2029 | Novartis | TASIGNA | nilotinib hydrochloride monohydrate |
➤ Sign Up | Jan 18, 2027 | Novartis | TASIGNA | nilotinib hydrochloride monohydrate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |